Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
+$1.75B |
| 2 |
VIAB
Viacom Inc. Class B
VIAB
|
+$1.62B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.21B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.11B |
| 5 |
Kraft Heinz
KHC
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.33B |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$1.39B |
| 3 |
Amazon
AMZN
|
+$1.32B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Apple
AAPL
|
+$938M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.04% |
| 2 | Communication Services | 12.94% |
| 3 | Industrials | 11.83% |
| 4 | Technology | 11.7% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
201
Charles Schwab
SCHW
$189B
| $245M | 0.09% |
8,565,620
-15,969,416
| -65% | -$512M |
|
|
TMH
202
DELISTED
Team Health Holdings Inc
TMH
| $243M | 0.09% |
4,499,767
+1,028,000
| +30% | +$64.2M |
|
203
JD.com
JD
$39B
| $241M | 0.09% |
9,247,343
+3,358,437
| +57% | +$97.1M |
|
204
Old Dominion Freight Line
ODFL
$45.1B
| $240M | 0.09% |
11,797,464
+3,905,727
| +49% | +$88.7M |
|
|
GWPH
205
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $239M | 0.09% |
2,610,674
+14,800
| +0.6% | +$1.65M |
|
206
AptarGroup
ATR
$8.41B
| $235M | 0.08% |
3,570,000
| – | – |
|
207
NRG Energy
NRG
$25.3B
| $234M | 0.08% |
15,736,065
-8,012,073
| -34% | -$159M |
|
208
Capital One
COF
$136B
| $232M | 0.08% |
3,200,000
| – | – |
|
209
TechnipFMC
FTI
$29.8B
| $226M | 0.08% |
9,811,200
-2,752,676
| -22% | -$69.2M |
|
210
Oshkosh
OSK
$9.36B
| $221M | 0.08% |
6,085,600
+421,600
| +7% | +$16.5M |
|
211
CMS Energy
CMS
$22.1B
| $217M | 0.08% |
6,130,499
-463,801
| -7% | -$15.6M |
|
|
OPLN
212
Openlane
OPLN
$4.35B
| $213M | 0.08% |
15,856,859
-1,978,226
| -11% | -$28.1M |
|
|
XLNX
213
DELISTED
Xilinx Inc
XLNX
| $213M | 0.08% |
5,025,000
+3,025,000
| +151% | +$127M |
|
|
SYNT
214
DELISTED
Syntel Inc
SYNT
| $212M | 0.08% |
4,688,043
+35,000
| +0.8% | +$1.53M |
|
215
Teva Pharmaceuticals
TEVA
$43.2B
| $210M | 0.07% |
3,712,000
| – | – |
|
|
K
216
DELISTED
Kellanova
K
| $208M | 0.07% |
3,334,965
| – | – |
|
217
Alexandria Real Estate Equities
ARE
$8.3B
| $208M | 0.07% |
2,455,904
| – | – |
|
218
Novartis
NVS
$289B
| $208M | 0.07% |
2,520,486
| – | – |
|
219
Bank of Montreal
BMO
$129B
| $206M | 0.07% |
3,770,426
-617,074
| -14% | -$33.9M |
|
|
NBIS
220
Nebius Group N.V.
NBIS
$69.8B
| $201M | 0.07% |
18,716,600
-7,878,000
| -30% | -$103M |
|
221
Autodesk
ADSK
$51.4B
| $200M | 0.07% |
4,530,000
| – | – |
|
222
D.R. Horton
DHI
$41.6B
| $196M | 0.07% |
6,685,000
| – | – |
|
223
Amphenol
APH
$210B
| $195M | 0.07% |
15,280,000
| – | – |
|
224
Graham Holdings Company
GHC
$5B
| $194M | 0.07% |
336,264
-110,028
| -25% | -$72.7M |
|
225
Moog Inc Class A
MOG.A
$13.6B
| $192M | 0.07% |
3,545,232
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Capital Research Global Investors held 460 positions worth $280B, down 8.1% from $304B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2015 filing shows 27 new, 141 increased, 116 reduced and 18 closed positions. Its largest new stake was Nielsen Holdings plc: 37,939,968 shares worth $1.69B. The largest sale was Gilead Sciences, an estimated $3.33B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Communication Services and Industrials.
- Capital Research Global Investors's largest Q3 2015 buy was Nielsen Holdings plc: 37,939,968 shares worth $1.69B.
- Capital Research Global Investors added most to Twenty-First Century Fox, Inc. Class A in Q3 2015, an estimated $1.21B increase.
- Capital Research Global Investors's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $3.33B.
- Capital Research Global Investors fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $1.39B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $280B portfolio in Q3 2015.
- Capital Research Global Investors opened 27 new positions and closed 18 in Q3 2015.
- Capital Research Global Investors's portfolio value fell 8.1% quarter-over-quarter to $280B.
Based on Capital Research Global Investors's 13F filing for Q3 2015, filed 16 Nov 2015.